MultiCare Health System

HomeBill PayMyChartAbout UsJobsWays to HelpFor ProvidersFor Staff

• Institute for Research & Innovation
  • About Us
  • Research
    • Clinical Trials
      • Cardiology
      • Cardiothoracic Surgery
      • Endocrinology
      • Gastroenterology
      • Genetics/Genomics
      • Inpatient Medicine
      • Internal Medicine
      • Neurology
      • Pulmonary Research
      • Surgery
      • Women's Health
       
    • Federal Research
    • Policies & Procedures
    • Sponsors & Collaborators
     
  • Participate in a Study
  • Become an Investigator
  • Information for Sponsors
  • Donate
   
 

Type II Diabetes - Controlling Insulin

Study Number: 12-END-03

Age: 18 yrs or older

Sex: Males and Females

Visits:  Patients will have office visits for a maximum of one year (17 weeks run-in, two 16-week treatment periods, 2 weeks follow-up)

Stipend: You will be compensated for your time and travel

Principal Investigator(s):  Ronald Graf, MD

Study Coordinator: Shannon Harris, Research Coordinator 253-301-6992

Purpose: To confirm the efficacy of XXX in controlling Type 2 Diabetes in high dose users of insulin after 16 weeks of treatment.